|
Volumn 7, Issue 5, 2001, Pages 311-335
|
The chemical and biological aspects of fluoroquinolones: Reality and dreams
|
Author keywords
[No Author keywords available]
|
Indexed keywords
1 CYCLOPROPYL 7 [3 [(ETHYLAMINO)METHYL] 1 PYRROLIDINYL] 6,8 DIFLUORO 1,4 DIHYDRO 4 OXO 3 QUINOLINECARBOXYLIC ACID;
1 ETHYL 6,8 DIFLUORO 1,4 DIHYDRO 4 OXO 7 (4 PYRIDYL) 3 QUINOLINECARBOXYLIC ACID;
1 ETHYL 7 [3 (ETHYLAMINOMETHYL) 1 PYRROLIDINYL] 6,8 DIFLUORO 1,4 DIHYDRO 4 OXO 3 QUINOLINECARBOXYLIC ACID;
5 AMINO 7 (3 AMINO 1 PYRROLIDINYL) 1 CYCLOPROPYL 6,8 DIFLUORO 1,4 DIHYDRO 4 OXO 3 QUINOLINECARBOXYLIC ACID;
7 (3 AMINO 1 PYRROLIDINYL) 1 CYCLOPROPYL 6,8 DIFLUORO 1,4 DIHYDRO 4 OXO 3 QUINOLINECARBOXYLIC ACID;
AMIFLOXACIN;
ANTIINFECTIVE AGENT;
BALOFLOXACIN;
BETA LACTAM ANTIBIOTIC;
CARBAPENEM;
CEPHALOSPORIN;
CEPHEM;
CIPROFLOXACIN;
CLINAFLOXACIN;
ENOXACIN;
FLEROXACIN;
GATIFLOXACIN;
GREPAFLOXACIN;
IRLOXACIN;
LOMEFLOXACIN;
NALIDIXIC ACID;
NORDIFLOXACIN;
NORFLOXACIN;
PEFLOXACIN;
PENEM DERIVATIVE;
PENICILLIN G;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
SPARFLOXACIN;
TEMAFLOXACIN;
UNINDEXED DRUG;
ABDOMINAL INFECTION;
ANTIBACTERIAL ACTIVITY;
ANTIBIOTIC RESISTANCE;
ARTHROPATHY;
ARTICLE;
BACTERIAL INFECTION;
CENTRAL NERVOUS SYSTEM DISEASE;
CHRONOLOGY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
DRUG ACTIVITY;
DRUG DESIGN;
DRUG EFFICACY;
DRUG MARKETING;
DRUG RESEARCH;
DRUG SYNTHESIS;
DRUG TARGETING;
DRUG TOLERABILITY;
DRUG TRANSPORT;
GASTROINTESTINAL DISEASE;
GASTROINTESTINAL INFECTION;
GYNECOLOGIC INFECTION;
HUMAN;
PATHOGENICITY;
PHOTOTOXICITY;
PRIORITY JOURNAL;
SHIGELLOSIS;
STRUCTURE ACTIVITY RELATION;
URINARY TRACT INFECTION;
ANTI-INFECTIVE AGENTS;
FLUOROQUINOLONES;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 0035043010
PISSN: 13816128
EISSN: None
Source Type: Journal
DOI: 10.2174/1381612013398059 Document Type: Article |
Times cited : (67)
|
References (126)
|